Endo targets 2020 for launch of cellulite treatment - PharmaLive (press release)

 
 
Endo targets 2020 for launch of cellulite treatmentPharmaLive (press release)icon_facebook icon_twitter icon_linkedin icon_rss Marketing & Advertising R&D Therapeutics Resources Manny Awards Events Issue Archives Login Advertise PharmaLive > R&D > Clinical Trials > Endo targets 2020 for launch of ...
 
Related NewsFeeds

BBC NewsDiabetes glucose monitors 'available to thousands more'BBC NewsWearable glucose monitors will be made available to tens of thousands more people with type 1 diabetes from April 2019, N

5 visits

Pharmaceutical Business ReviewFDA grants priority review to Tecentriq combo for triple-negative breast cancerPharmaceutical Business ReviewRoche has secured priority review from the US Food and Drug A

0 visits

News-Medical.netPrecision medicine-based approach to slow or reverse biologic drivers of Alzheimer's diseaseNews-Medical.netThe software is designed to execute a precision-medicine-based approach

0 visits

Enable Injections enters into development agreements with UCB and Apellis PharmaceuticalsNews-Medical.net"We are conducting human clinical trials using the enFuse technology to deliver our novel compl

0 visits

Labiotech.eu (press release) (blog)Taking Biotech to the Next Level with Laboratory AutomationLabiotech.eu (press release) (blog)Automation is slowly taking over our lives, ranging from smart homes to

0 visits

ISRAEL21cIsraeli scientists develop implanted organs made from patient's own cellsISRAEL21cCurrently, in tissue engineering for regenerative medicine, cells are isolated from the patient and cultu

0 visits

The Sentinel-EchoSaint Joseph London educating public on effective ways to control diabetes during the holidaysThe Sentinel-EchoNovember marks the beginning of Diabetes Awareness Month, and Saint Jose

0 visits

TechCrunchBiotech holding company Roivant Sciences raised $200M in funding at a whopping $7B valuationTechCrunchRoivant Sciences has had a bumpy couple of years, but that isn't stopping investors

0 visits

Imprimis Pharmaceuticals, Inc. (IMMY) CEO Mark Baum on Q3 2018 Results - Earnings Call TranscriptSeeking AlphaImprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Q3 2018 Results Conference Call November 13,

0 visits

Tullahoma News and GuardianCumberland Pharmaceuticals, Inc. (CPIX) CEO AJ Kazimi on Q3 2018 Results - Earnings Call TranscriptSeeking AlphaCumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q3 2018 Earnin

0 visits

The LancetFamily matters in diabetes careThe LancetWorld Diabetes Day takes place each year on Nov 14-the birthday of Frederick Banting, the Canadian physician and scientist who shared the 1923 Nobel

0 visits

Zacks.comCumberland Pharmaceuticals (CPIX) Reports Q3 Loss, Misses Revenue EstimatesZacks.comCumberland Pharmaceuticals (CPIX - Free Report) came out with a quarterly loss of $0.05 per share versus th

0 visits

Nikkei Asian ReviewSamsung's hopes for biotech arm hinge on fraud rulingNikkei Asian ReviewSEOUL -- Samsung's long-term growth strategy will come under scrutiny on Wednesday when South Korean

0 visits

Precision NanoSystems and Entos Pharmaceuticals sign license agreement for the use of the NanoAssemblr ...Bristol Herald Courier (press release) (blog)VANCOUVER, Nov. 13, 2018 /PRNewswire/ - Precision

0 visits

NC Dept of Commerce (press release)Biotechnology & PharmaceuticalsNC Dept of Commerce (press release)In addition to our high quality of life, North Carolina boasts some of the best competitive advanta

0 visits

Large babies born to mothers with diabetes have a near-trebled risk of obesityEurekAlert (press release)New research published in Diabetologia (the journal of the European Association for the Study of

0 visits

Clearfield ProgressBlood glucose monitoring important for diabetes controlClearfield ProgressNovember is American Diabetes Month, an important time to raise awareness and understanding of diabetes. Ap

0 visits

General Electric: Big Opportunities In BiotechSeeking AlphaA large chunk of General Electric is dedicated to the Healthcare space, but beneath the service, a lot of what it does is focus on biotech. T

0 visits

fox13now.comWhat is healthy eating for diabetes?fox13now.comAround eight percent of Utahns have diabetes and that number is expected to continue to rise. A healthy diet is especially important for peo

0 visits

Cumberland Pharmaceuticals beats by $0.20, misses on revenueSeeking AlphaCumberland Pharmaceuticals beats by $0.20, misses on revenue. Nov. 13, 2018 4:09 PM ET |About: Cumberland Pharmaceutica... (CPI

0 visits